Abstract
Background
Patients with advanced cancer are highly susceptible to infections. The decision whether to treat an active or suspected infection or to withhold or withdraw an antibiotic treatment in end-of-life care may be difficult. In order to quantify the antimicrobial prescribing practices and decision-making processes in palliative care units in Germany, a survey was performed as part of the Hospice and Palliative Evaluation in 2006.
Method
With a specifically designed questionnaire, 448 patients for whom an active or suspected infection and antibiotic treatment was discussed were documented. Data on the use of and indication for antibiotic treatment and the decision-making on withdrawal or withholding of antibiotic therapy were collected.
Results
286 (63.8%) received an antibiotic therapy. In 88 cases, withdrawal of an ongoing treatment was documented. The most frequent reasons for withdrawal were: deterioration of general status (41.4%), inefficiency of therapy (25.7%), and explicit wish of patient (14.3%; multiple answers possible). Outcome of antimicrobial therapy was rated poor or very poor for a fifth of the cases and accordingly, antibiotics were more likely to be withdrawn if the clinical success was considered to be poor. The initiation of therapy was often decided by physicians solely, whereas withdrawing and withholding therapy demanded more often involvement of other team members in the decision-making process.
Conclusion
The initiation of therapy seems to be easier than withdrawing and withholding, as involvement of other team members in the decision-making process was then sought more often. When antibiotics were given until death, the indication should be reconsidered because of a possibly undesirable prolongation of the dying process. Clinical practice may benefit from clear definitions of treatment goals and outcome criteria to better evaluate the necessity for and success of antimicrobial treatment.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Hallenbeck J (2003) Palliative care perspective. Oxford University Press, New York
Pestinger M et al (2004) Antibiotika in der Palliativmedizin: Ergebnisse einer Fokusgruppe. Zeitschrift für Palliativmedizin 5:68–74
Hickman S et al (2009) Use of the physician orders for life-sustaining treatment (POLST) paradigm program in the hospice setting. J Palliat Med 12(2):133–141
Grossenbacher-Gschwend B, Eychmüller S (2007) Der liverpool care pathway of the dying. Onkologe 13:343–349
Green K et al (1994) Management of nosocomial respiratory tract infections in terminally ill cancer patients. J Palliat Care 10(4):31–34
Oneschuk D et al (2002) Antibiotic use in the last week of life in three different palliative care settings. J Palliat Care 18(1):25–28
Pereira J et al (1998) A retrospective review of the frequency of infections and patterns of antibiotic utilization on a palliative care unit. J Pain Symptom Manage 16(6):374–381
Vitetta L et al (2000) Bacterial infections in terminally ill hospice patients. J Pain Symptom Manage 20(5):326–334
Sorbye LW (1992) Has the care of dying patients in hospitals changed? A study of terminal care at the Diaconal hospital in 1977 and 1987. Tidsskr Nor Laegeforen 112(10):1264–1267
Evers MM et al (2002) Palliative and aggressive end-of-life care for patients with dementia. Psychiatr Serv 53(5):609–613
Sorbye LW (2000) A longitudinal study on dying in a Norwegian hospital. Int J Palliat Nurs 6(2):71–79
White PH et al (2003) Antimicrobial use in patients with advanced cancer receiving hospice care. J Pain Symptom Manage 25(5):438–443
Bundesamt für Verbraucherschutz und Lebensmittelsicherheit. Bericht über den Antibiotikaverbrauch und die Verarbeitung von Antibiotikaresistenzen in der Human- und Veteriärmedizin in Deutschland, http://www.bvl.bund.de/cln_007/DE/08__PresseInfothek/00__doks__downloads/Germap__2008,templateId=raw,property=publicationFile.pdf/Germap_2008.pdf. Accessed August 2010
Paul-Ehrlich Gesellschaft für Chemotherapie e. V. rationaler Einsatz oraler Antibiotika bei Erwachsenen und Schulkinder (Lebenslater ab 6 Jahre), http://www.wissenschaftliche-verlagsgesellschaft.de/CTJ/CTJ2006/ctj-5-06/consensus-orale-2006.pdf. Accessed August 2010
Goossens H et al (2005) Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365(9459):579–587
HOPE Clara (2007) http://www.hope-clara.de/download/HOPE2007Basisbogen.pdf. Accessed August 2010
HOPE Clara (2007) http://www.hope-clara.de/download/HOPE2007Expose.pdf. Accessed August 2010
Radbruch L et al (2002) What is palliative care in Germany? Results from a representative survey. J Pain Symptom Manage 23(6):471–483
Lindena G et al (2005) Quality assurance in palliative medicine—results of the core documentation of 1999–2002. Z Ärztl Fortbild Qualitätssich 99(9):555–565
HOPE Clara (2009) https://www.hope-clara.de/download/HOPE2009DGPForschungAntibiotika.pdf. Accessed August 2010
D’Agata E, Mitchell SL (2008) Patterns of antimicrobial use among nursing home residents with advanced dementia. Arch Intern Med 168(4):357–362
Clayton J et al (2003) Parenteral antibiotics in a palliative care unit: prospective analysis of current practice. Palliat Med 17(1):44–48
Bausewein C et al. (2005) Infektionen. Arzneimitteltherapie in der Palliativmedizin. In: Bausewein C, Remi C, Tmycross R, Wilcock A (eds.) vol. 2. Urban & Fischer: München
HOPE Clara (2008) https://www.hope-clara.de/download/GesamtberichtHOPE2008.pdf. Accessed August 2010
Nauck F et al (2004) Drugs in palliative care: results from a representative survey in Germany. Palliat Med 18(2):100–107
Oh DY et al (2006) Antibiotic use during the last days of life in cancer patients. Eur J Cancer Care (Engl) 15(1):74–79
Radbruch L et al (2000) MIDOS—validation of a minimal documentation system for palliative medicine. Schmerz 14(4):231–239
Jubelirer SJ et al (2001) Competencies and concerns in end-of-life care for medical students and residents. W V Med J 97(2):118–121
Acknowledgements
This case study received a grant from the German Cancer Aid (DKH, 105803). We thank the participating palliative care units and caregivers for documentation and supporting this evaluation.
The evaluation of HOPE was supported by an unrestricted grant of Mundipharma GmbH, Limburg. HOPE is supported by the German Palliative Care Association, the German Hospice Association, and the German Cancer Association.
Conflict of interests
The authors have no conflict of interests to declare.
Author information
Authors and Affiliations
Corresponding author
Additional information
Members of the HOPE Steering Group are: Norbert Krumm, Gabriele Lindena, Friedemann Nauck, Christoph Ostgathe, Lukas Radbruch, Claudia Bausewein, Steffen Eychmüller, Petra Feyer, Martin Fuchs, Ute Heinze, Karl Neuwöhner, and Josef Roß
Annex: German version of the antibiotics questionnaire
Annex: German version of the antibiotics questionnaire
Rights and permissions
About this article
Cite this article
Stiel, S., Krumm, N., Pestinger, M. et al. Antibiotics in palliative medicine—results from a prospective epidemiological investigation from the HOPE survey. Support Care Cancer 20, 325–333 (2012). https://doi.org/10.1007/s00520-011-1084-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-011-1084-1